PL1820792T3 - Sposób otrzymywania adamantanoamin - Google Patents
Sposób otrzymywania adamantanoaminInfo
- Publication number
- PL1820792T3 PL1820792T3 PL06003477T PL06003477T PL1820792T3 PL 1820792 T3 PL1820792 T3 PL 1820792T3 PL 06003477 T PL06003477 T PL 06003477T PL 06003477 T PL06003477 T PL 06003477T PL 1820792 T3 PL1820792 T3 PL 1820792T3
- Authority
- PL
- Poland
- Prior art keywords
- formula
- treatment
- adamantanamine
- disease
- methyl
- Prior art date
Links
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical class C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 2
- 229960003805 amantadine Drugs 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 238000010306 acid treatment Methods 0.000 abstract 1
- 229960001280 amantadine hydrochloride Drugs 0.000 abstract 1
- WOLHOYHSEKDWQH-UHFFFAOYSA-N amantadine hydrochloride Chemical compound [Cl-].C1C(C2)CC3CC2CC1([NH3+])C3 WOLHOYHSEKDWQH-UHFFFAOYSA-N 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229960000967 memantine hydrochloride Drugs 0.000 abstract 1
- LDDHMLJTFXJGPI-UHFFFAOYSA-N memantine hydrochloride Chemical compound Cl.C1C(C2)CC3(C)CC1(C)CC2(N)C3 LDDHMLJTFXJGPI-UHFFFAOYSA-N 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 230000036967 uncompetitive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/06—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/62—Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/30—Isothioureas
- C07C335/32—Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06003477A EP1820792B1 (en) | 2006-02-21 | 2006-02-21 | Process for the preparation of adamantanamines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1820792T3 true PL1820792T3 (pl) | 2012-06-29 |
Family
ID=36754153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06003477T PL1820792T3 (pl) | 2006-02-21 | 2006-02-21 | Sposób otrzymywania adamantanoamin |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090082596A1 (pl) |
| EP (1) | EP1820792B1 (pl) |
| JP (1) | JP5235683B2 (pl) |
| CN (1) | CN101389594B (pl) |
| AT (1) | ATE541827T1 (pl) |
| AU (1) | AU2007218140B2 (pl) |
| CA (1) | CA2640127C (pl) |
| DK (1) | DK1820792T3 (pl) |
| ES (1) | ES2379181T3 (pl) |
| PL (1) | PL1820792T3 (pl) |
| PT (1) | PT1820792E (pl) |
| SI (1) | SI1820792T1 (pl) |
| WO (1) | WO2007096124A1 (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1908748A1 (en) * | 2006-10-05 | 2008-04-09 | Krka | Process for the preparation of memantine and its hydrochloric acid salt form |
| WO2010007351A1 (en) * | 2008-07-14 | 2010-01-21 | Cipla Limited | Process for the preparation of memantine and its salts and intermediate for use therein |
| CN101560157B (zh) * | 2009-06-02 | 2013-09-18 | 王彦明 | 盐酸金刚烷胺生产工艺及其专用设备 |
| CN102070463A (zh) * | 2009-06-11 | 2011-05-25 | 辽宁利锋科技开发有限公司 | 具有金刚烷结构药物美金刚胺及其衍生物和类似物抗肿瘤新适应症的应用 |
| PL2448910T3 (pl) * | 2009-06-29 | 2013-10-31 | Merz Pharma Gmbh & Co Kgaa | Sposób wytwarzania nerameksanu |
| CA2765743A1 (en) * | 2009-06-29 | 2011-01-06 | Merz Pharma Gmbh & Co. Kgaa | Method of preparing 1-chloroacetamido-1,3,3,5,5-pentamethylcyclohexane |
| US20120116125A1 (en) * | 2009-06-29 | 2012-05-10 | Merz Pharma Gmbh & Co. Kgaa | Method of preparing neramexane |
| PL2448909T3 (pl) * | 2009-06-29 | 2013-09-30 | Merz Pharma Gmbh & Co Kgaa | Sposób wytwarzania 1-amino-1,3,3,5,5-pentametylocykloheksanu |
| CN101993377A (zh) * | 2009-08-07 | 2011-03-30 | 出光兴产株式会社 | 具有金刚烷骨架的胺类和季铵盐的制造方法 |
| WO2014115638A1 (ja) * | 2013-01-23 | 2014-07-31 | 三菱瓦斯化学株式会社 | メマンチンの製造プロセス |
| CN103483205B (zh) * | 2013-10-12 | 2015-02-04 | 合肥久诺医药科技有限公司 | 一种高纯度盐酸美金刚的制备方法 |
| CN103524353B (zh) * | 2013-10-12 | 2015-03-25 | 合肥久诺医药科技有限公司 | 一种高纯度盐酸美金刚的制备方法 |
| CN104693039B (zh) * | 2015-01-06 | 2016-11-16 | 中山大学 | 一种金刚烷胺类衍生物及其制备方法和应用 |
| CN105399636A (zh) * | 2015-12-18 | 2016-03-16 | 天津民祥生物医药股份有限公司 | 一种利用盐酸金刚烷胺制备金刚烷胺游离胺的工艺 |
| CN117843492A (zh) * | 2023-12-04 | 2024-04-09 | 四川众邦新材料股份有限公司 | 金刚烷胺生产中的产物分离提取方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3391142A (en) | 1966-02-09 | 1968-07-02 | Lilly Co Eli | Adamantyl secondary amines |
| CH603545A5 (pl) * | 1972-04-20 | 1978-08-31 | Merz & Co | |
| DE2318461A1 (de) | 1973-04-12 | 1974-10-31 | Merz & Co | Verfahren zur herstellung von 1,3,5trisubstituierten adamanta-verbindungen |
| SU805609A1 (ru) * | 1979-10-12 | 1981-09-30 | Предприятие П/Я В-2343 | S-(1-адамантилкарбпмоилметил) изотиуроний хлорид,обладающий антивирусной активностью |
| ES2059602T3 (es) | 1989-04-14 | 1994-11-16 | Merz & Co Gmbh & Co | Uso de derivados de adamantano para la prevencion y tratamiento de isquemia cerebral. |
| US5948820A (en) * | 1994-08-22 | 1999-09-07 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzene compound and pharmaceutical use thereof |
| CZ288445B6 (en) | 1996-06-20 | 2001-06-13 | Lachema Np | Process for preparing hydrochloride of 5-amino-1,3-dimethyltricyclo(3,3,1,1 3,7 )decane |
| GB0001093D0 (en) | 2000-01-19 | 2000-03-08 | F2 Chemicals Ltd | Selective nitrogen functionalisation of organic compounds |
| GB0018272D0 (en) * | 2000-07-25 | 2000-09-13 | Vernalis Research Limited | Chemical compounds IV |
| JP4118555B2 (ja) * | 2001-12-13 | 2008-07-16 | 株式会社トクヤマ | Ｎ−（アダマンチル）アミド化合物の製造方法 |
| RU2246482C2 (ru) | 2002-12-25 | 2005-02-20 | ООО "Циклан" | Способ получения гидрохлорида 1-амино-3,5-диметиладамантана |
| CN1240668C (zh) | 2003-09-10 | 2006-02-08 | 上海医药工业研究院 | 一种新的盐酸美金刚制备方法 |
| WO2005062724A2 (en) * | 2003-12-31 | 2005-07-14 | Sun Pharmaceutical Industries Limited | Novel process for the preparation of aminoadamantane derivatives |
| CA2554617A1 (en) * | 2004-01-22 | 2005-08-04 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist |
| US7456224B2 (en) * | 2004-04-05 | 2008-11-25 | Forest Laboratories Holdings, Ltd. | Method for treating autism |
| WO2006122238A1 (en) * | 2005-05-11 | 2006-11-16 | Dr. Reddy's Laboratories Ltd. | Process for preparing memantine |
-
2006
- 2006-02-21 DK DK06003477.4T patent/DK1820792T3/da active
- 2006-02-21 PT PT06003477T patent/PT1820792E/pt unknown
- 2006-02-21 EP EP06003477A patent/EP1820792B1/en not_active Not-in-force
- 2006-02-21 AT AT06003477T patent/ATE541827T1/de active
- 2006-02-21 ES ES06003477T patent/ES2379181T3/es active Active
- 2006-02-21 SI SI200631279T patent/SI1820792T1/sl unknown
- 2006-02-21 PL PL06003477T patent/PL1820792T3/pl unknown
-
2007
- 2007-02-20 CA CA2640127A patent/CA2640127C/en not_active Expired - Fee Related
- 2007-02-20 CN CN2007800060848A patent/CN101389594B/zh not_active Expired - Fee Related
- 2007-02-20 US US12/224,147 patent/US20090082596A1/en not_active Abandoned
- 2007-02-20 WO PCT/EP2007/001440 patent/WO2007096124A1/en not_active Ceased
- 2007-02-20 AU AU2007218140A patent/AU2007218140B2/en not_active Ceased
- 2007-02-20 JP JP2008555684A patent/JP5235683B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1820792A1 (en) | 2007-08-22 |
| WO2007096124A1 (en) | 2007-08-30 |
| SI1820792T1 (sl) | 2012-04-30 |
| DK1820792T3 (da) | 2012-04-10 |
| JP2009527517A (ja) | 2009-07-30 |
| ES2379181T3 (es) | 2012-04-23 |
| EP1820792B1 (en) | 2012-01-18 |
| JP5235683B2 (ja) | 2013-07-10 |
| CN101389594B (zh) | 2013-06-12 |
| AU2007218140B2 (en) | 2010-08-19 |
| CN101389594A (zh) | 2009-03-18 |
| CA2640127A1 (en) | 2007-08-30 |
| PT1820792E (pt) | 2012-04-10 |
| CA2640127C (en) | 2015-08-11 |
| ATE541827T1 (de) | 2012-02-15 |
| AU2007218140A1 (en) | 2007-08-30 |
| US20090082596A1 (en) | 2009-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1820792T1 (sl) | Postopek za pripravo adamantanaminov | |
| TW200833682A (en) | Pharmaceutical compounds | |
| UA102817C2 (ru) | Способ синтеза агомелатина | |
| EP2765130A3 (en) | Process for producing pyrrole compound | |
| UA100367C2 (uk) | Спосіб одержання мемантину і його гідрохлориду | |
| IL183244A0 (en) | Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride | |
| MX2010001905A (es) | Sal de metal alcalino de acido glutamico acido n,n-diacetico, un proceso para preparar dicha sal, y el uso de la misma. | |
| UA93225C2 (ru) | 3'-алкоксиспироциклопентилзамещенные производные тетрамовой кислоты и гербицидное средство ha их ochobe | |
| NZ600119A (en) | Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives | |
| EP2298734A3 (en) | Cyclobutyl amine derivatives | |
| EP1604989A8 (en) | DPP-IV inhibitors | |
| TW200833657A (en) | Novel process | |
| UA83691C2 (ru) | Применение замещенных 2-аминотетралинов для упреждающего лечения болезни паркинсона | |
| UA102220C2 (ru) | Способ синтеза агомелатина | |
| MX2009000480A (es) | Bencilaminas, un proceso para su produccion y su uso como agentes antiinflamatorios. | |
| MY151017A (en) | 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents | |
| WO2006113471A3 (en) | N-alkyl-azacycloalkyl nmda/nr2b antagonists | |
| MY148769A (en) | Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments | |
| JO2928B1 (en) | A method for the preparation of ferroquine with amine by convergent reduction | |
| TW200714598A (en) | Urea derivatives, methods for their manufacture, and uses therefor | |
| TW200633977A (en) | Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives | |
| MY179041A (en) | Crystalline forms of a 3-carboxypropyl-aminotetralin compound | |
| UA100843C2 (uk) | Поліморфні форми сульфатів зипразидону | |
| AU2003290055A1 (en) | Improved neutralization of isophorone nitrile synthesis products | |
| BRPI0702817A (pt) | compostos de naftaleno, processo para sua preparação e composições farmacêuticas que contêm esses compostos |